Philips receives high score for its ESG practices from S&P Global Ratings

March 30, 2021

Philips received a score of 90 out of 100, the highest that S&P Global Ratings has awarded to date

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its strategy to do business responsibly and sustainably has been validated by S&P Global Ratings. Evaluated across the Environmental, Social and Governance (ESG) dimensions of S&P Global Ratings’ assessment, Philips received a score of 90 out of 100, the highest that S&P Global Ratings has awarded to date.

“As a purpose-driven company, we are conscious of our responsibility towards society and of the need to continue to embed ESG practices ever deeper in the way we do business,” said Frans van Houten, CEO of Royal Philips. “I am proud that this commitment has again been recognized externally, receiving the highest score to date in the S&P Global Ratings ESG Evaluation. This sends a strong message to investors and our other stakeholders, who increasingly look to a company’s ESG actions as a measure of its commitment to doing business in a responsible and sustainable manner.”

S&P Global Ratings’ ESG Evaluation assesses a company’s ESG strategy and ability to prepare for potential future risks and opportunities and is used by investors as a forward looking, long-term opinion of a company’s readiness for disruptive ESG risks and opportunities. It provides an overall ESG Score that allows comparison with other entities globally, including sector peers.

“Our ESG Evaluation score of 90 reflects our view that sustainability is at the core of Philips’ corporate strategy,” states S&P Global Ratings in its evaluation report. “The company built a digital, integrated, and solution-based business model before most of its global peers, which it leverages to respond to key challenges in the health care industry, such as inequality in the access and affordability of care, and shortages of medical professionals.”

In the Environmental domain, S&P Global Ratings notes that “Philips applies leading environmental standards across its value chain” and “distinguishes itself in the management of its indirect environmental impact.” It also recognizes that “Philips has a track record of setting and achieving more ambitious targets in its direct operations than many of its industry peers.”

In the Social domain, Philips is recognized for being “better positioned than many industry peers to provide access to medical care to customers and communities because of its diversified regional footprint and portfolio of products and services.” The report also applauds “Philips’ commitment to pay a living wage to all its staff…”, and recognizes that “its management of human rights risk in its supply chain sets the company apart from peers.”

For Governance, S&P Global Ratings notes that “Philips’ governance structure follows the Dutch Corporate Governance Code…”, which the report views as “aligned with international best practices”. The evaluation also notes that “Philips has comprehensive financial and sustainability disclosures audited by an external auditor…”, including “policies on most material environmental and social risks, and approaches used to calculate key performance indicators, including green revenue and millions of lives improved.”

Enhanced ESG framework
In September 2020, as part of its ongoing commitment to making the world healthier and more sustainable through innovation, Philips launched an enhanced and fully integrated approach to doing business responsibly and sustainably. This framework comprises a comprehensive set of targets, commitments, and action plans across all the Environmental, Social and Governance dimensions that will drive further growth while acting responsibly towards the planet and society.

The full report is available here.

For further information, please contact:

Ben Zwirs
Philips Global Press Office
Tel.: +31 6 15213446
E-mail: [email protected]

Derya Guzel
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: [email protected]

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries. News about Philips can be found at



Latest News

Conagen’s Novel Solution to Making Natural Capsaicin by Fermentation Accessible

Bedford, Mass., April 22, 2021 (GLOBE NEWSWIRE) — Scalable, sustainable capsaicin ingredients for its use in food, consumer and industrial products have now become more accessible. Conagen announced it has successfully scaled-up its fermentation process for the production of premium capsaicin and its related capsaicinoid molecules. Chili peppers are widely used as a food additive in spicy […]

Global Pandemic Fueled Renewed Investor Interest in Silver in 2020

Record Silver-Backed Exchange-Traded Product Inflows Drove Global Holdings to Over One Billion Ounces; Coin and Bar Demand Rose to a Four-Year High WASHINGTON, April 22, 2021 (GLOBE NEWSWIRE) — Considerable growth in silver investment was the chief driver of the metal’s 27 percent average price gain in 2020. Leading the way was substantial demand for […]

โรงงานใหม่ของ Nikkiso Cryo Inc. เพิ่มการผลิตปั๊มไครโอเจนิค

ลาสเวกัส, April 22, 2021 (GLOBE NEWSWIRE) — Nikkiso Cryo Inc. (NCI) ในเมืองลาสเวกัส รัฐเนวาดา ซึ่งเป็นสมาชิกของ Nikkiso Clean Energy and Industrial Gases Group (กลุ่ม) และเป็นส่วนหนึ่งของ Nikkiso Co., Ltd (ญี่ปุ่น) ได้ประกาศเกี่ยวกับโรงงานใหม่ซึ่งจะเพิ่มประสิทธิภาพและขีดความสามารถในการผลิตปั๊มไครโอเจนิค โรงงานใหม่ที่ใหญ่ขึ้นของ NCI เป็นสิ่งจำเป็นเนื่องจากการเติบโตและความต้องการผลิตภัณฑ์และบริการปั๊มไครโอจีนิคอย่างต่อเนื่องของตลาด LNG ทั่วโลก (หลักๆ คือสถานีส่งออกและนำเข้า LNG) โรงงานสำนักงานขนาด 15,000 ตารางฟุตอยู่ใกล้กับสถานที่ทดสอบการผลิตหลัก ซึ่งมีการปรับปรุงประสิทธิภาพในการดำเนินงาน ความปลอดภัย และขีดความสามารถในการผลิตที่เพิ่มขึ้นอย่างมาก ในจำนวนนี้ยังมีระบบหอเผาทิ้งระดับพื้นดินใหม่ที่มีประสิทธิภาพและขีดความสามารถในการผลิตที่ดีขึ้น อีกทั้งยังมีการติดตั้งเครนโอเวอร์เฮดไฟฟ้าประเภทที่ 1 แบบที่ 1 บนแผงทดสอบ ซึ่งช่วยลดต้นทุนและเพิ่มผลผลิตโดยช่วยให้สามารถทำงานหลายอย่างในเวลาเดียวกัน เพิ่มความปลอดภัยโดยอนุญาตให้สามารถยกและติดตั้งปั๊มหลายตัวสำหรับการทดสอบ รวมถึงได้รับการรับรองสำหรับพื้นที่อันตราย “นี่เป็นก้าวต่อไปที่น่าตื่นเต้นสำหรับบริษัทของเราและเป็นประโยชน์อย่างมากสำหรับลูกค้าของเรา NCI จะสามารถเพิ่มผลผลิตและลดเวลาในการผลิตได้” Daryl […]

AB InBev 100+ Accelerator partners with The Coca-Cola Company, Colgate-Palmolive and Unilever for Sustainable Startup Innovation

NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) — Today, The Coca-Cola Company, Colgate-Palmolive Company and Unilever have joined the Anheuser-Busch InBev (AB InBev) 100+ Accelerator to fund and pilot sustainable innovation in supply chains. Launched in 2018, the 100+ Accelerator is a global incubator program that works to solve supply chain challenges across water stewardship, […]